On October 30, Tonbo Biotech announced that it had completed Series A financing of nearly 100 million yuan. This round of financing was co-led by Zhengxin Valley Capital, the Innovation Factory US Dollar Fund, an industrial medical fund, and the old shareholder Yuansheng Venture Capital continued to be added.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.